The global spine biologics market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. The market is driven by the widespread adoption of minimally invasive surgeries (MIS), the growing geriatric population, the growing access to healthcare services on account o... https://www.imarcgroup.com/spine-biologics-market